Thermal properties of dough and bakery products : a review of published data = Propriétés thermiques de la pâte et des produits de boulangerie : une synthèse des résultats publiésRASK, C.Journal of food engineering. 1989, Vol 9, Num 3, pp 167-193, issn 0260-8774Article

A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infectionMCARTHUR, J. C; YIANNOUTSOS, C; NAVIA, B. A et al.Neurology. 2000, Vol 54, Num 5, pp 1080-1088, issn 0028-3878Article

Sorption isotherms of mixed minced meat, dough, and bread crustLIND, I; RASK, C.Journal of food engineering. 1991, Vol 14, Num 4, pp 303-315, issn 0260-8774Article

Antibodies and antibody-secreting cells in the female genital tract after vaginal or intranasal immunization with cholera toxin B subunit or conjugatesJOHANSSON, E.-L; RASK, C; FREDRIKSSON, M et al.Infection and immunity. 1998, Vol 66, Num 2, pp 514-520, issn 0019-9567Article

Evaluation of clinical assays for measuring high-dose methotrexate in plasmaALBERTIONI, F; RASK, C; EKSBORG, S et al.Clinical chemistry (Baltimore, Md.). 1996, Vol 42, Num 1, pp 39-44, issn 0009-9147Article

Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel : clinical trial designLAMMERTSE, D; TUSZYNSKI, M. H; KLEITMAN, N et al.Spinal cord. 2007, Vol 45, Num 3, pp 232-242, issn 1362-4393, 11 p.Article

Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel : clinical trial inclusion/exclusion criteria and ethicsTUSZYNSKI, M. H; STEEVES, J. D; ELLAWAY, P. H et al.Spinal cord. 2007, Vol 45, Num 3, pp 222-231, issn 1362-4393, 10 p.Article

Danish patients with untreated multiple myeloma do not harbour human herpesvirus 8RASK, C; KELSEN, J; OLESEN, G et al.British journal of haematology. 2000, Vol 108, Num 1, pp 96-98, issn 0007-1048Article

Mucosal and systemic antibody responses after peroral or intranasal immunization : Effects of conjugation to enterotoxin B subunits and/or of co-administration with free toxin as adjuvantRASK, C; FREDRIKSSON, M; LINDBLAD, M et al.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 2000, Vol 108, Num 3, pp 178-186, issn 0903-4641Article

Oral mucositis in children with acute lymphoblastic leukemia after high-dose methotrexate treatment without delayed elimination of methotrexate : Relation to pharmacokinetic parameters of methotrexateRASK, C; ALBERTIONI, F; SCHRØDER, H et al.Pediatric hematology and oncology. 1996, Vol 13, Num 4, pp 359-367, issn 0888-0018Article

An alternative allergen:adjuvant formulation potentiates the immunogenicity and reduces allergenicity of a novel subcutaneous immunotherapy product for treatment of grass-pollen allergyRASK, C; LUND, L; LUND, G et al.Clinical and experimental allergy (Print). 2012, Vol 42, Num 9, pp 1356-1368, issn 0954-7894, 13 p.Article

Mucosal immunity and tolerance : relevance to vaccine developmentCZERKINSKY, C; ANJUERE, F; SUN, J.-B et al.Immunological reviews. 1999, Vol 170, pp 197-222, issn 0105-2896Article

Methotrexate plasma pharmacokinetics : importance of assay methodEKSBORG, S; ALBERTIONI, F; RASK, C et al.Cancer letters. 1996, Vol 108, Num 2, pp 163-169, issn 0304-3835Article

Prolonged oral treatment with low doses of allergen conjugated to cholera toxin B subunit suppresses immunoglobulin E antibody responses in sensitized miceRASK, C; HOLMGREN, J; FREDRIKSSON, M et al.Clinical and experimental allergy (Print). 2000, Vol 30, Num 7, pp 1024-1032, issn 0954-7894Article

Clinical and pharmacokinetic risk factors for high-dose methotrexate-induced toxicity in children with acute lymphoblastic leukemia: A logistic regression analysisRASK, C; ALBERTIONI, F; BENTZEN, S. M et al.Acta oncologica (Stockholm). 1998, Vol 37, Num 3, pp 277-284, issn 0284-186XArticle

Intradermal recombinant human nerve growth factor induces pressure allodynia and lowered heat-pain threshold in humansDYCK, P. J; PEROUTKA, S; RASK, C et al.Neurology. 1997, Vol 48, Num 2, pp 501-505, issn 0028-3878Article

Simultaneous quantitation of methotrexate and its two main metabolites in biological fluids by a novel solid-phase extraction procedure using high-performance liquid chromatographyALBERTIONI, F; PETTERSSON, B; BECK, O et al.Journal of chromatography. B, Biomedical applications. 1995, Vol 665, Num 1, pp 163-170Article

Biological actions of nerve growth factor in the peripheral nervous systemRASK, C. A.European neurology. 1999, Vol 41, pp 14-19, issn 0014-3022, SUP1Conference Paper

Neurotrophin treatment of peripheral sensory neuropathiesRASK, C. A; ESCANDON, E.Handbook of experimental pharmacology. 1999, Vol 134, pp 53-79, issn 0171-2004Article

Clinical manifestations in children with occipital spike-wave paroxysmsTALWAR, D; RASK, C. A; TORRES, F et al.Epilepsia (Copenhagen). 1992, Vol 33, Num 4, pp 667-674, issn 0013-9580Article

Effects of estradiol and progesterone on seizure sensitivity in oophorectomized DBA/2J mice and C57/EL hybrid miceHOM, A. C; LEPPIK, I. E; RASK, C. A et al.Neurology. 1993, Vol 43, Num 1, pp 198-204, issn 0028-3878Article

Recombinant human nerve growth factor in the treatment of diabetic polyneuropathyAPFEL, S. C; KESSLER, J. A; ADORNATO, B. T et al.Neurology. 1998, Vol 51, Num 3, pp 695-702, issn 0028-3878Article

Pharmacokinetics and safety of a phenytoin prodrug given IV or IM in patientsLEPPIK, I. E; BOUCHER, B. A; WILDER, B. J et al.Neurology. 1990, Vol 40, Num 3, pp 456-460, issn 0028-3878, 5 p., 1Article